Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Didierlaurent

Showing results (91-100 of 144) with videos related to

Pageof 15
Sort By:
The Journal of Experimental Medicine|January 30, 2008
Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infectionArnaud Didierlaurent, John Goulding, Seema Patel, et al.
Frontiers in Immunology|October 2, 2019
Application of Modeling Approaches to Explore Vaccine Adjuvant Mode-of-ActionPaul R Buckley, Kieran Alden, Margherita Coccia, et al.
NPJ Vaccines|March 8, 2023
Systems serology-based comparison of antibody effector functions induced by adjuvanted vaccines to guide vaccine designCarolin Loos, Margherita Coccia, Arnaud M Didierlaurent, et al.
Scientific Reports|December 21, 2016
Central Role of CD169<sup>+</sup> Lymph Node Resident Macrophages in the Adjuvanticity of the QS-21 Component of AS01Sophie Detienne, Iain Welsby, Catherine Collignon, et al.
Vaccine|January 25, 2011
Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunitySandra Morel, Arnaud Didierlaurent, Patricia Bourguignon, et al.
Frontiers in Immunology|January 21, 2017
Lysosome-Dependent Activation of Human Dendritic Cells by the Vaccine Adjuvant QS-21Iain Welsby, Sophie Detienne, Francisca N'Kuli, et al.
Frontiers in Immunology|June 8, 2017
Predicting RTS,S Vaccine-Mediated Protection from Transcriptomes in a Malaria-Challenge Clinical TrialRobert A van den Berg, Margherita Coccia, W Ripley Ballou, et al.
Science Translational Medicine|July 31, 2024
Functional and epigenetic changes in monocytes from adults immunized with an AS01-adjuvanted vaccineViviane Bechtold, Kinga K Smolen, Wivine Burny, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2009
AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunityArnaud M Didierlaurent, Sandra Morel, Laurence Lockman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 16, 2014
Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cellsArnaud M Didierlaurent, Catherine Collignon, Patricia Bourguignon, et al.
Pageof 15

Showing results (91-100 of 144) with videos related to

Sort By:
Pageof 15
The Journal of Experimental Medicine|January 30, 2008
Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infectionArnaud Didierlaurent, John Goulding, Seema Patel, et al.
Frontiers in Immunology|October 2, 2019
Application of Modeling Approaches to Explore Vaccine Adjuvant Mode-of-ActionPaul R Buckley, Kieran Alden, Margherita Coccia, et al.
NPJ Vaccines|March 8, 2023
Systems serology-based comparison of antibody effector functions induced by adjuvanted vaccines to guide vaccine designCarolin Loos, Margherita Coccia, Arnaud M Didierlaurent, et al.
Scientific Reports|December 21, 2016
Central Role of CD169<sup>+</sup> Lymph Node Resident Macrophages in the Adjuvanticity of the QS-21 Component of AS01Sophie Detienne, Iain Welsby, Catherine Collignon, et al.
Vaccine|January 25, 2011
Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunitySandra Morel, Arnaud Didierlaurent, Patricia Bourguignon, et al.
Frontiers in Immunology|January 21, 2017
Lysosome-Dependent Activation of Human Dendritic Cells by the Vaccine Adjuvant QS-21Iain Welsby, Sophie Detienne, Francisca N'Kuli, et al.
Frontiers in Immunology|June 8, 2017
Predicting RTS,S Vaccine-Mediated Protection from Transcriptomes in a Malaria-Challenge Clinical TrialRobert A van den Berg, Margherita Coccia, W Ripley Ballou, et al.
Science Translational Medicine|July 31, 2024
Functional and epigenetic changes in monocytes from adults immunized with an AS01-adjuvanted vaccineViviane Bechtold, Kinga K Smolen, Wivine Burny, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2009
AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunityArnaud M Didierlaurent, Sandra Morel, Laurence Lockman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 16, 2014
Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cellsArnaud M Didierlaurent, Catherine Collignon, Patricia Bourguignon, et al.
Pageof 15